ADHD Trial, Recruiting (NCT05637320)

ADHD Trial, Recruiting NCT05637320 Sponsor: University of Guelph Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT05637320 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child must be between 8 and 15 years old and be able to speak and understand English
The parent or guardian must be over 18 years old and be able to speak and understand English
The family must be looking for mental health support related to anxiety, depression, or difficult behaviours in the child

Who may not be able to join:

The child has significant learning or cognitive difficulties that would make it hard for them to take part in the research activities
The child is currently having thoughts of suicide that require urgent or hospital-level care
The child has been diagnosed with psychosis, schizophrenia-related conditions, an eating disorder, or autism spectrum disorder
The child does not agree or is unwilling to take part in the study themselves

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristel Thomassin, PhD, University of Guelph

Phone: 519-824-4120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05637320

Sponsor: University of Guelph

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: 519-824-4120

More information: https://clinicaltrials.gov/study/NCT05637320

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child must be between 8 and 15 years old and be able to speak and understand English
The parent or guardian must be over 18 years old and be able to speak and understand English
The family must be looking for mental health support related to anxiety, depression, or difficult behaviours in the child

Who may not be able to join:

The child has significant learning or cognitive difficulties that would make it hard for them to take part in the research activities
The child is currently having thoughts of suicide that require urgent or hospital-level care
The child has been diagnosed with psychosis, schizophrenia-related conditions, an eating disorder, or autism spectrum disorder
The child does not agree or is unwilling to take part in the study themselves

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Guelph

Registry

ClinicalTrials.gov

Start date

1 October 2022

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in parent-rated child psychopathology symptoms; Change in child self-reported psychopathology symptoms; Change in child psychopathology symptoms (past week); Change in child emotional-behavioural problems; Change in child impairment; Change in ratings of child emotion regulation; Change in child physiological emotion regulation (heart rate variability); Change in child physiological emotion regulation (skin conductance)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov